Metropolitan Life Insurance Company (MetLife)’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,987
| Closed | -$112K | – | 2643 |
|
|
2021
Q4 | $112K | Hold |
6,987
| – | – | ﹤0.01% | 2413 |
|
|
2021
Q3 | $129K | Hold |
6,987
| – | – | ﹤0.01% | 2373 |
|
|
2021
Q2 | $97.5K | Buy |
6,987
+1,802
| +35% | +$25.2K | ﹤0.01% | 2600 |
|
|
2021
Q1 | $76.3K | Sell |
5,185
-1,405
| -21% | -$20.7K | ﹤0.01% | 2484 |
|
|
2020
Q4 | $128K | Buy |
+6,590
| New | +$128K | ﹤0.01% | 2223 |
|
|
2020
Q3 | – | Sell |
-5,227
| Closed | -$70.7K | – | 2590 |
|
|
2020
Q2 | $70.7K | Buy |
+5,227
| New | +$70.7K | ﹤0.01% | 2433 |
|